Anti-Tumor Activity of Cabozantinib by FAK down-Regulation in Human Oral Squamous Cell Carcinoma. Bangladesh J Pharmacol 2015, 11 (1), 119-125. https://doi.org/10.3329/bjp.v11i1.24001.